Phonozen-mediated photodynamic therapy comparing two wavelengths in a mouse model of peritoneal carcinomatosis

[1] Azaïs H(2020)A global approach for the development of photodynamic therapy of peritoneal metastases regardless of their origin Photodiagnosis and Photodynamic Therapy 30 12-18

[2] Rebahi C(2010)Pathophysiology and biology of peritoneal carcinomatosis World Journal of Gastrointestinal Oncology 2 1852-1857

[3] Baydoun M(1993)A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan lung cancer photodynamic therapy study group Journal of Clinical Oncology 11 425-433

[4] Serouart B(2005)Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment Endoscopy 37 441-446

[5] Ziane L(2004)Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer British Journal of Cancer 91 24-32

[6] Moralès O(2010)Taking treatment decisions in non-melanoma skin cancer–the place for topical photodynamic therapy (PDT) Photodiagnosis and Photodynamic Therapy 7 445-457

[7] Frochot C(1993)Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors International Journal of Radiation Oncology, Biology, Physics 25 2517-2525

[8] Colombeau L(2006)A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis Clinical Cancer Research 12 23-30

[9] Thécua E(1997)Intraoperative Meso-Tetrahydroxyphenylchlorin-based photodynamic therapy in metastatic gynecologic cancer tissue: initial results Journal of Gynecologic Surgery 13 228-232

[10] Collinet P(1995)Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer Annals of Surgical Oncology 2 1-10

[1] Azaïs H(2020)A global approach for the development of photodynamic therapy of peritoneal metastases regardless of their origin Photodiagnosis and Photodynamic Therapy 30 12-18

[2] Rebahi C(2010)Pathophysiology and biology of peritoneal carcinomatosis World Journal of Gastrointestinal Oncology 2 1852-1857

[3] Baydoun M(1993)A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan lung cancer photodynamic therapy study group Journal of Clinical Oncology 11 425-433

[4] Serouart B(2005)Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment Endoscopy 37 441-446

[5] Ziane L(2004)Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer British Journal of Cancer 91 24-32

[6] Moralès O(2010)Taking treatment decisions in non-melanoma skin cancer–the place for topical photodynamic therapy (PDT) Photodiagnosis and Photodynamic Therapy 7 445-457

[7] Frochot C(1993)Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors International Journal of Radiation Oncology, Biology, Physics 25 2517-2525

[8] Colombeau L(2006)A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis Clinical Cancer Research 12 23-30

[9] Thécua E(1997)Intraoperative Meso-Tetrahydroxyphenylchlorin-based photodynamic therapy in metastatic gynecologic cancer tissue: initial results Journal of Gynecologic Surgery 13 228-232

[10] Collinet P(1995)Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer Annals of Surgical Oncology 2 1-10